Zhou, Jinmei
Wu, Xuexue
Du, Yimeng
Xiao, Jinyi
Kang, Xiaofeng
Chen, Jiaxin
Wang, Xiaobo
Tai, Yanhong
Bian, Li
Zhang, Shaohua
Pang, Zheng
Li, Yang
Jiang, Zefei https://orcid.org/0000-0002-4295-0173
Xu, Xiaojie https://orcid.org/0000-0002-7337-4308
Wang, Tao https://orcid.org/0000-0002-2823-7937
Article History
Received: 29 August 2025
Accepted: 27 February 2026
First Online: 20 March 2026
Competing interests
: Zheng Pang and Yang Li are employees of Jiangsu Hengrui Pharmaceuticals, which provided dalpiciclib for this study. The company had no role in study design, data collection, analysis, interpretation, or manuscript preparation. All other authors declare no competing interests.